International Journal of Clinical Medicine

Volume 6, Issue 12 (December 2015)

ISSN Print: 2158-284X   ISSN Online: 2158-2882

Google-based Impact Factor: 0.52  Citations  h5-index & Ranking

Correlation of Hormonal Receptors Estrogen Receptor, Progesterone Receptor and Her-2/Neu with Tumor Characteristics in Breast Carcinoma: Study of 100 Consecutive Cases

HTML  XML Download Download as PDF (Size: 479KB)  PP. 961-966  
DOI: 10.4236/ijcm.2015.612126    4,909 Downloads   5,966 Views  Citations

ABSTRACT

Introduction-Breast cancer is the most common cancer and leading cause of death in women. In India, its incidence is rapidly rising over last few decades. Present study is aimed to study the pattern of expression of hormonal receptors and Her-2/neu in invasive breast carcinoma and to correlate estrogen receptor (ER), progesterone receptor (PR) and Her-2/neu expressions with various clinicopathological parameters. Material and methods: The present study was carried out in Department of Pathology, S.C.B. Medical College, Cuttack in the year 2013 taking consecutive 100 cases. Routine H&E staining for histological diagnosis and IHC analysis for ER, PR and Her 2/neu was carried out in all 100 cases of breast malignancies. Results: 99% of cases are invasive breast carcinoma, not otherwise specify (IDC-NOS). The age ranges from 23 years to 72 years. Majority of tumors are of grade 2 (70%) followed by grade 3 (30%). ER PR and Her-2/neu expression are seen in 45%, 35% and 30% respectively. Triple negative cases comprise 35%. Higher number of grade 2 tumor shows ER, PR positivity as compared to grade 3 tumors. Her-2/neu expression does not show any significant correlation with age or lymph node status of the patient. Conclusion: ER and PR expression in breast cancers in the current study are found to be comparable to the findings of other authors, but the frequency of HER-2/neu expression is slightly higher. Significant correlation is observed between hormonal receptor status and the grade of the tumor. Inverse relationship is found between Her-2/neu expression and ER, PR receptor status. Her-2/neu expression is increased with size and high grade of tumor.

Share and Cite:

Biswal, P. , Behera, S. , Kar, A. , Pradhan, D. , Kumar Behera, P. , Burma, S. and Mishra, C. (2015) Correlation of Hormonal Receptors Estrogen Receptor, Progesterone Receptor and Her-2/Neu with Tumor Characteristics in Breast Carcinoma: Study of 100 Consecutive Cases. International Journal of Clinical Medicine, 6, 961-966. doi: 10.4236/ijcm.2015.612126.

Cited by

[1] Role of p53 and Her2/Neu as a prognostic biomarker in breast carcinoma
2023
[2] Immunohistochemical Study on Hormone Receptors and HER2 Status in Invasive Breast Carcinoma and its Therapeutic Implications
2019
[3] Comparison of fine needle aspiration cytology and core needle biopsy findings with excisional biopsy in breast malignancy
2019
[4] Prognostic subtyping based on estrogen receptor, progesterone receptor, and human epidermal growth factor receptor2 expression in breast cancer cases among north Indian females
International Journal of Community Medicine and Public Health, 2018
[5] Prognostic subtyping based on estrogen receptor, progesterone receptor, and human epidermal growth factor receptor2 expression in breast cancer …
2018
[6] Clinicopathological and immunohistological profile of infiltrating ductal carcinoma breast in a tertiary care centre of western UP-A study of 100 cases
2018
[7] Incidence, Epidemiology and Clinico-Pathological Status of Different Molecular Subtypes of Breast Cancer in NICRH, Dhaka
Delta Medical College Journal, 2018
[8] Correlation between hormonal receptor status and Her 2 neu expression with the age of breast cancer patients and its outcome: a single institutional study in Egypt
Cancer Biology, 2017
[9] STATUS OF KI67 INDEX AND TP53 GENE EXPRESSION IN PRIMARY BREAST CARCINOMA: AN IMMUNOHISTOCHEMICAL ASSESSMENT
2017
[10] Correlation of Expression of ER, PR with the onset age, histopathological grading, size of tumor and metastatic behavior of invasive duct cell carcinoma breast
2016

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.